P. Helissey et al., SYNTHESIS, ANTITUMOR EVALUATION AND SAR OF NEW 1H-PYRROLO [3,2-C] QUINOLINE-6,9-DIONES AND 11H-INDOLO [3,2-C] QUINOLINE-1,4-DIONES, Anti-cancer drug design, 9(1), 1994, pp. 51-67
New 1H-pyrrolo [3,2-c] quinoline-6,9-diones, 11H-indolo [3,2-c] quinol
ine-1,4-diones and 7,8,9,10-tetrahydro-11H-indolo [3,2-c] quinoline-1,
4-diones, either unsubstituted or methylated, have been synthesized an
d evaluated for antitumor activity. They were compared to previously d
escribed quinones which bear either a methoxy group or an aziridinyl s
ubstituent on the quinone nucleus in order to establish structure-acti
vity relationships and to obtain compounds as active as aziridinyl-qui
nones, but with less toxicity. A new synthetic route was developed usi
ng dimethoxy derivatives as key compounds that reacted with ceric ammo
nium nitrate (CAN) to give quinones by oxidation demethylation. The bi
ological results obtained in vitro indicated that: (i) new quinones di
splay cytotoxicity higher than that of the methoxyquinones; (ii) unsub
stituted compounds are the most active; (iii) methylation of the pyrro
le NH has no influence on unsubstituted quinones, but affords inactive
derivatives when the quinone nucleus is methylated; (iv) compared to
the aziridinyl-quinones, some compounds are equally active or more act
ive. Despite the cytotoxicity exerted in vitro, we could not find evid
ence for any antitumor activity of quinones against in vivo P388 murin
e leukemia.